XTRA:BAYNPharmaceuticals
Assessing Bayer (XTRA:BAYN) Valuation After Leadership Shift In U.S. Pharmaceuticals
Bayer’s leadership reshuffle in U.S. pharmaceuticals
Bayer (XTRA:BAYN) has announced that Nelson Ambrogio will become President of Bayer U.S. Pharmaceuticals from May 1, 2026. This leadership shift focuses on its largest and fastest growing pharmaceutical market.
See our latest analysis for Bayer.
Bayer’s recent announcement comes as the share price stands at €40.48, with a 30 day share price return of 7.69% and a 1 year total shareholder return of 108.93%, while longer term total shareholder...